Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

Former U.S. assistant secretary for health Admiral Joxel Garcia joins Flurotest advisory board

Admiral Joxel Garcia Former U.S. assistant secretary for health and four-star Admiral Joxel Garcia, M.D. joined FluroTest’s (TSXV:TEST; OTCQB:FLURF) advisory board. Dr. Garcia will help support FluroTest...

April 6, 2021

Executive Moves

Oppenheimer expands healthcare investment banking team

Oppenheimer (NYSE:OPY) continued to build out its healthcare leadership team, adding three members to its healthcare investment banking team: Jonathan Fassberg, in the newly created role of vice chairman; Brian Korb, as...

March 24, 2021

Executive Moves

KA Imaging adds world renowned radiologist Philip Templeton as CMO

X-ray manufacturer, KA Imaging, appointed Dr. Philip Templeton, M.D., to the newly created position of chief medical officer (CMO). A board certified radiologist, Dr. Templeton brings over 38 years of academic and...

March 8, 2021

Executive Moves

Medtech analyst Raj Denhoy joins Establishment Labs as head of strategy, IR

Establishment Labs Holdings (NASDAQ: ESTA) appointed Raj Denhoy as head of strategy and investor relations to help define and execute the company’s corporate strategy and communicate that vision to investors and other...

March 3, 2021

Executive Moves

Profound Medical appoints healthcare investment professional Cynthia Lavoie to board

Profound Medical (NASDAQ:PROF; TSX:PRN) appointed seasoned healthcare investment professional Cynthia Lavoie, Ph.D., to the board of the commercial-stage medical device company that develops and markets customizable...

March 3, 2021

Executive Moves

Nurx names telehealth pioneer Jennifer Peña as CMO

Nurx, a telehealth platform providing convenient and affordable care for female health needs, appointed Dr. Jennifer Peña, M.D., as chief medical officer to help Nurx build on a record year of growth and begin treating...

March 1, 2021

Executive Moves

PYC Therapeutics adds industry veteran Glenn Noronha as CDO

Glenn Noronha Glenn Noronha, PhD, has joined PYC Therapeutics (ASX:PYC) as chief development officer to oversee the company’s translational clinical development, regulatory, manufacturing and preclinical development...

February 23, 2021

Executive Moves

Hepion names renowned clinician Dr. Todd Hobbs as CMO

Todd Hobbs Hepion Pharmaceuticals (NASDAQ:HEPA) appointed Todd Hobbs, M.D., to the newly created position of chief medical officer, effective Feb. 16, 2021. In this role, Dr. Hobbs will help lead Hepion as it engages...

February 10, 2021

Executive Moves

PharmaJet names Marian Wentworth to board

Marian Wentworth Closely-held PharmaJet appointed Marian Wentworth, president and CEO of Management Sciences for Health since 2017, to its board. Management Sciences for Health is a non-profit organization that works...

February 9, 2021

Executive Moves

Jim Lilly joins England & Co. in healthcare investment banking

Jim Lilly Jim Lilly joined England & Co., a middle-market investment bank, as a managing director in its New York office. Mr. Lilly brings more than 30 years of experience as a strategic advisor to a wide variety of...

January 19, 2021

Executive Moves

Justin Zelin joins BTIG as biotech analyst

Justin Zelin BTIG has expanded its healthcare research coverage, adding Justin Zelin to its research and strategy division as a director. His biotech research coverage will include cell therapy, targeted oncology...

January 15, 2021

Executive Moves

IntelGenx names Tommy Kenny as VP of intellectual property and legal affairs, general counsel

Tommy Kenny IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) appointed Tommy Kenny as VP intellectual property and legal affairs, general counsel of IntelGenx Corp., the company’s operating subsidiary. Mr. Kenny has been...

January 13, 2021

Executive Moves

Fibrocor Therapeutics names biotech veteran Joseph Walewicz as CFO

Joseph Walewicz Closely-held Fibrocor Therapeutics appointed Joseph Walewicz, a biotech veteran with more than 25 years of experience in finance, capital markets and business development, as CFO. Prior to joining...

January 7, 2021

Executive Moves

PDS Biotechnology names Seth Van Voorhees as CFO

Seth Van Voorhees PDS Biotechnology (NASDAQ:PDSB) appointed Seth Van Voorhees, Ph.D., as its new CFO, effective Jan. 1, 2021. He replaces Michael King, who served as interim CFO. Dr. Van Voorhees most recently was CFO...

December 9, 2020

Executive Moves

Benjamin Bowen joins Roth’s healthcare investment banking team

Benjamin Bowen Benjamin Bowen, Ph.D., has joined Roth Capital Partners as managing director, healthcare investment banking. Prior to joining Roth, Dr. Bowen most recently was managing director in the investment banking...

December 4, 2020

Executive Moves

Profound Medical appoints accomplished financial executive, Murielle Lortie, to board

Murielle Lortie Profound Medical (NASDAQ:PROF; TSX:PRN) appointed financial executive, Murielle Lortie, as a director, effective immediately. Ms. Lortie is the CFO of Liminal Biosciences, a Nasdaq-listed, clinical-stage...

November 30, 2020

Executive Moves

ObsEva names Brian O’Callaghan as CEO

Brian O’Callaghan ObsEva (NASDAQ:OBSV) appointed Brian O’Callaghan as CEO, effective Dec. 1. He succeeds ObsEva’s co-founder, Ernest Loumaye, M.D., Ph.D., who is retiring from his role as CEO but will remain a...

November 9, 2020

Executive Moves

Marizyme names Neil Campbell as president and CEO

Marizyme (NASDAQ:MRZM) appointed Neil Campbell, Ph.D., as CEO, replacing executive chairman James Sapirstein, who has been the company’s interim CEO since September 2020. Dr. Campbell currently serves as chairman of...

November 6, 2020

Executive Moves

LogicBio names Mariana Nacht as CSO; Kyle Chiang as COO

LogicBio Therapeutics (NASDAQ:LOGC) appointed Mariana Nacht, Ph.D., as CSO, effective Nov. 30; and promoted Kyle Chiang, Ph.D., to the role of COO, effective Nov. 2. The company is expanding its leadership team to...

November 3, 2020

Executive Moves

Aethlon Medical names Charles Fisher as CEO

Aethlon Medical (NASDAQ:AEMD) appointed Charles Fisher, M.D., as CEO, effective Oct. 30. Dr. Fisher joined Aethlon as a member of its board and served as its chairman since November 2017. He succeeds Dr. Timothy Rodell...

November 3, 2020

Executive Moves

Soliton appoints Brad Hauser as president, CEO

Brad Hauser Soliton (NASDAQ:SOLY) named Brad Hauser as president and CEO as the company prepares for its commercial launch. Mr. Hauser most recently was VP of R&D and general manager for CoolSculpting at Allergan...

November 2, 2020

Executive Moves

Fibrocor names William Fanslow as SVP drug development

William Fanslow Closely-held Fibrocor Therapeutics appointed industry veteran, William Fanslow Ph.D., as SVP of drug development. Dr. Fanslow has more than 20 years of experience in drug development, including both...

October 26, 2020

Subscribe